Neumora Therapeutics Inc (NMRA)

Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	47.31% 60.07	114.00	56.86	-	-
Operating Income/Loss	47.31% -60.07	-114.00	-56.86	-	-
Nonoperating Income/Loss	14.63% 6.353	5.542	3.837	-	-
Income/Loss From Continuing Operations Before Tax	50.47% -53.72	-108.46	-53.03	-38.54	-35.62
Income/Loss From Continuing Operations After Tax	50.59% -53.72	-108.73	-53.03	-38.54	-35.62
Net Income/Loss	50.59% -53.72	-108.73	-53.03	-38.54	-35.62
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	433.72% 157.94	29.59	46.69	-	-
Diluted Average Shares	433.72% 157.94	29.59	46.69	-	-
Basic Earnings Per Share	750.00% -0.34	-0.04	-1.14	-	-
Diluted Earnings Per Share	750.00% -0.34	-0.04	-1.14	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-